Psyence

Toronto, Canada Founded: 1997 • Age: 29 yrs
Developer of psychedelic therapeutics for mental health disorders

About Psyence

Psyence is a company based in Toronto (Canada) founded in 1997 by Jody Aufrichtig and Alan Friedman.. Psyence offers products and services including Natural Psilocybin Products, Medicinal Formulations, and Functional Mushroom Wellness Products. Psyence operates in a competitive market with competitors including ATAI, COMPASS Pathways, Beckley Psytech, MindMed and Cybin, among others.

  • Headquarter Toronto, Canada
  • Founders Jody Aufrichtig, Alan Friedman
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Psyence Group Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
    $0 (USD)
    0
    as on Mar 31, 2024
  • Net Profit
    $-278.66 K (USD)
    99.42
    as on Mar 31, 2025
  • EBITDA
    $-3.84 M (USD)
    -6.69
    as on Mar 31, 2025
  • Latest Funding Round
    $441.14 K (USD), Post-IPO

    Jun 18, 2025

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Psyence

Psyence is a publicly listed company on the CSE with ticker symbol PSYG in Canada, operating in the Industrial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: CSE · Ticker: PSYG . Sector: Industrial services · Canada

Products & Services of Psyence

Psyence offers a comprehensive portfolio of products and services, including Natural Psilocybin Products, Medicinal Formulations, and Functional Mushroom Wellness Products. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Formulations for mental health treatment in clinical settings

Protocols targeting anxiety and depression in palliative care

Adaptogens for stress relief and general wellness benefits

People of Psyence
Headcount 1-10
Employee Profiles 5
Board Members and Advisors 6
Employee Profiles
People
Neil Maresky
CEO
People
Tony Budden
Chief Strategy Officer
People
Taryn Vos
General Counsel
People
Clive Ward-Able
Medical Director

Unlock access to complete

Board Members and Advisors
people
Xan Morgan
European Director & Advisory Board Member
people
Jody Aufrichtig
Co-Founder, Executive Chairman & Director
people
Alan Friedman
Capital Markets Advisor & Director
people
Marvin Singer
Independent Director

Unlock access to complete

Funding Insights of Psyence

  • Total Funding
  • Total Rounds 6
  • Last Round Post-IPO — $441,139
  • First Round

    (02 Dec 2021)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2025 Amount Post-IPO - Psyence Valuation

investors

Dec, 2024 Amount Post-IPO - Psyence Valuation

investors

Aug, 2023 Amount Post-IPO - Psyence Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Psyence

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Psyence

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Psyence Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Psyence

Psyence operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ATAI, COMPASS Pathways, Beckley Psytech, MindMed and Cybin, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
A biopharmaceutical company accelerating innovative mental health treatments.
domain founded_year HQ Location
Therapies for mental disorders, including psilocybin for depression, are developed.
domain founded_year HQ Location
Developer of drugs for the treatment of neurological and psychiatric disorders
domain founded_year HQ Location
Psychedelic-based therapies for brain health disorders are developed.
domain founded_year HQ Location
Psychedelic therapeutics for psychiatric disorders are developed and provided.
domain founded_year HQ Location
Non-hallucinogenic therapeutics for neurological disorders are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Psyence

Frequently Asked Questions about Psyence

When was Psyence founded?

Psyence was founded in 1997 and raised its 1st funding round 24 years after it was founded.

Where is Psyence located?

Psyence is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.

Who is the current CEO of Psyence?

Jody Aufrichtig is the current CEO of Psyence. They have also founded this company.

What does Psyence do?

Developer of psychedelic therapeutics for mental health disorders. The companys psilocybin drug candidates reduce the symptoms of psychological trauma, PTSD, depression, anxiety, stress, and addiction.

Who are the top competitors of Psyence?

Psyence's top competitors include MindMed, COMPASS Pathways and Beckley Psytech.

What products or services does Psyence offer?

Psyence offers Natural Psilocybin Products, Medicinal Formulations, and Functional Mushroom Wellness Products.

Is Psyence publicly traded?

Yes, Psyence is publicly traded on CSE under the ticker symbol PSYG.

What is Psyence's ticker symbol?

The ticker symbol of Psyence is PSYG on CSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available